Bryan L. Benson
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Bryan L. Benson has a total of 79 co-authors. Here are the top co-authors by number of shared publications:
- Rachael D. Seidler
Department of Applied Physiology and Kinesiology, University of Florida, Gainesville, USA
5 shared publications - Alex Yee-Chen Huang
Department of Pathology, Case Western Reserve University School of Medicine, Cleveland, USA
4 shared publications - Derek W. Abbott
Department of Pathology, Case Western Reserve University School of Medicine, Cleveland, Ohio, USA
2 shared publications Jessica A. Bernard
Department of Psychology
2 shared publications- Jie Yang
Department of Biochemistry and Molecular Genetics, University of Virginia
2 shared publications - Joaquin A. Anguera
Neuroscape, Department of Neurology, University of California San Francisco, San Francisco, CA, United States
2 shared publications
Latest Publications
- Open Access
- 21 January 2026
- Published by Royal Society of Chemistry (RSC) in Lab on a Chip
- Vol. 26 (4) , 976-990
Microfluidic capillary transit velocity as a functional measure for sickle cell disease and in vitro -derived red blood cells
This study presents a biomimetic microfluidic assay to evaluate the capillary transit velocity of red blood cells at single-cell resolution, highlighting heterogeneity and therapeutic effects in sickle cell disease and in vitro derived cells.
- 21 January 2026
- Published by Royal Society of Chemistry (RSC) in Lab on a Chip
- Vol. 26 (4) , 976-990
Open AccessMicrofluidic capillary transit velocity as a functional measure for sickle cell disease and in vitro -derived red blood cells
This study presents a biomimetic microfluidic assay to evaluate the capillary transit velocity of red blood cells at single-cell resolution, highlighting heterogeneity and therapeutic effects in sickle cell disease and in vitro derived cells.
- Open Access
- 1 May 2020
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 204 (1_Suppleme) , 165.38
Detailing the mechanism of CDK5-mediated PD-L1 regulation in Medulloblastoma
Novel therapies for the pediatric brain tumor medulloblastoma (MB) are hindered by limited knowledge of the roles played by host-derived cells at the local tumor site. Immune resistance in a murine model of MB (MM1) is associated with enhanced tumor expression of programmed death ligand-1 (PD-L1) in response to anti-tumor cytokine interferon-gamma (IFNγ) signaling. Disrupting this pathway via knockdown of cyclin dependent kinase 5 (CDK5), an essential transducer of the IFNγ signal, leads to an inflammatory tumor microenvironment (TME) and enhanced tumor rejection in vivo. In this study, we sought to detail the mechanism of CDK5-mediated PD-L1 regulation. In response to IFNγ, PD-L1 expression is thought to be regulated at the promoter level by competition between the transcriptional activator IRF1 and repressor IRF2. We hypothesized that CDK5-IFNγ signaling inhibits IRF2 activity, resulting in unleashed PD-L1 promoter activity. We assessed IRF1/IRF2-DNA interactions using chromatin immunoprecipitation (ChIP) and gene reporter assays, with complementary analysis of PD-L1 transcription and surface expression with IRF1/IRF2 depletion. ChIP-qPCR revealed a similar, IFNγ-induced enrichment of both IRF1 and IRF2 at the PD-L1 promoter. This is a surprising result, given the assumption that they compete for the same binding site and exert opposing effects. Additionally, inducible PD-L1 promoter activity was found to be decreased in tumors with IRF2 depletion. Together, these results suggest that IRF2 may be necessary for full activity of the PD-L1 promoter in MB. IRF1/IRF2 also bind to other cis-regulatory sites at genes that contribute to tumor immunogenicity, necessitating genome-wide characterization of their interactions.
- 1 May 2020
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 204 (1_Suppleme) , 165.38
Open AccessDetailing the mechanism of CDK5-mediated PD-L1 regulation in Medulloblastoma
Novel therapies for the pediatric brain tumor medulloblastoma (MB) are hindered by limited knowledge of the roles played by host-derived cells at the local tumor site. Immune resistance in a murine model of MB (MM1) is associated with enhanced tumor expression of programmed death ligand-1 (PD-L1) in response to anti-tumor cytokine interferon-gamma (IFNγ) signaling. Disrupting this pathway via knockdown of cyclin dependent kinase 5 (CDK5), an essential transducer of the IFNγ signal, leads to an inflammatory tumor microenvironment (TME) and enhanced tumor rejection in vivo. In this study, we sought to detail the mechanism of CDK5-mediated PD-L1 regulation. In response to IFNγ, PD-L1 expression is thought to be regulated at the promoter level by competition between the transcriptional activator IRF1 and repressor IRF2. We hypothesized that CDK5-IFNγ signaling inhibits IRF2 activity, resulting in unleashed PD-L1 promoter activity. We assessed IRF1/IRF2-DNA interactions using chromatin immunoprecipitation (ChIP) and gene reporter assays, with complementary analysis of PD-L1 transcription and surface expression with IRF1/IRF2 depletion. ChIP-qPCR revealed a similar, IFNγ-induced enrichment of both IRF1 and IRF2 at the PD-L1 promoter. This is a surprising result, given the assumption that they compete for the same binding site and exert opposing effects. Additionally, inducible PD-L1 promoter activity was found to be decreased in tumors with IRF2 depletion. Together, these results suggest that IRF2 may be necessary for full activity of the PD-L1 promoter in MB. IRF1/IRF2 also bind to other cis-regulatory sites at genes that contribute to tumor immunogenicity, necessitating genome-wide characterization of their interactions.
- Open Access
- 22 January 2020
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 204 (5) , 1188-1200
Chronic Methadone Use Alters the CD8+ T Cell Phenotype In Vivo and Modulates Its Responsiveness Ex Vivo to Opioid Receptor and TCR Stimuli
Endogenous opioid peptides are released at sites of injury, and their cognate G protein–coupled opioid receptors (ORs) are expressed on immune cells. Although drugs of misuse appropriate ORs, conflicting reports indicate immunostimulatory and immunosuppressive activity, in that opioid users have elevated infection risk, opioids activate innate immune cells, and opioids attenuate inflammation in murine T cell–mediated autoimmunity models. The i.v. use of drugs transmits bloodborne pathogens, particularly viruses, making the study of CD8+ T cells timely. From a cohort of nonuser controls and methadone users, we demonstrate, via t-Stochastic Neighbor Embedding and k-means cluster analysis of surface marker expression, that chronic opioid use alters human CD8+ T cell subset balance, with notable decreases in T effector memory RA+ cells. Studying global CD8+ T cell populations, there were no differences in expression of OR and several markers of functionality, demonstrating the need for finer analysis. Purified CD8+ T cells from controls respond to opioids ex vivo by increasing cytoplasmic calcium, a novel finding for OR signal transduction, likely because of cell lineage. CD8+ T cells from controls exposed to μ-OR agonists ex vivo decrease expression of activation markers CD69 and CD25, although the same markers are elevated in μ-OR–treated cells from methadone users. In contrast to control cells, T cell subsets from methadone users show decreased expression of CD69 and CD25 in response to TCR stimulus. Overall, these results indicate a direct, selective role for opioids in CD8+ T cell immune regulation via their ability to modulate cell responses through the opioid receptors and TCRs.
- 22 January 2020
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 204 (5) , 1188-1200
Open AccessChronic Methadone Use Alters the CD8+ T Cell Phenotype In Vivo and Modulates Its Responsiveness Ex Vivo to Opioid Receptor and TCR Stimuli
Endogenous opioid peptides are released at sites of injury, and their cognate G protein–coupled opioid receptors (ORs) are expressed on immune cells. Although drugs of misuse appropriate ORs, conflicting reports indicate immunostimulatory and immunosuppressive activity, in that opioid users have elevated infection risk, opioids activate innate immune cells, and opioids attenuate inflammation in murine T cell–mediated autoimmunity models. The i.v. use of drugs transmits bloodborne pathogens, particularly viruses, making the study of CD8+ T cells timely. From a cohort of nonuser controls and methadone users, we demonstrate, via t-Stochastic Neighbor Embedding and k-means cluster analysis of surface marker expression, that chronic opioid use alters human CD8+ T cell subset balance, with notable decreases in T effector memory RA+ cells. Studying global CD8+ T cell populations, there were no differences in expression of OR and several markers of functionality, demonstrating the need for finer analysis. Purified CD8+ T cells from controls respond to opioids ex vivo by increasing cytoplasmic calcium, a novel finding for OR signal transduction, likely because of cell lineage. CD8+ T cells from controls exposed to μ-OR agonists ex vivo decrease expression of activation markers CD69 and CD25, although the same markers are elevated in μ-OR–treated cells from methadone users. In contrast to control cells, T cell subsets from methadone users show decreased expression of CD69 and CD25 in response to TCR stimulus. Overall, these results indicate a direct, selective role for opioids in CD8+ T cell immune regulation via their ability to modulate cell responses through the opioid receptors and TCRs.
- Open Access
- 17 July 2019
- Published by Frontiers Media SA in Frontiers in Neuroscience
- Vol. 13, 737
Insights From Dynamic Neuro-Immune Imaging on Murine Immune Responses to CNS Damage
Technological advances in 2-Photon Laser Scanning Microscopy (2P-LSM) have allowed novel insights into in vivo immune response in a variety of tissue microenvironments. While imaging of peripheral tissues has provided an abundance of data with regards to immune cell dynamics, central nervous system (CNS) imaging is comparatively inhibited by tissue accessibility and manipulation. Despite these limitations, the results of dynamic intravital neuro-immune imaging thus far have provided foundational insights into basic CNS biology. Utilizing a combination of intravital and ex vivo 2P-LSM we have observed novel pathways allowing immune cells, stromal cells, cancer cells and proteins to communicate between the CNS parenchyma and peripheral vasculature. Similar to what has been reported in the intestinal tract, we have visualized myeloid cells extend dendritic processes across the blood brain barrier (BBB) into pial blood vessels. Furthermore, transient vessel leaks seen during systemic inflammation provide opportunities for cellular protein to be exchanged between the periphery and CNS. These insights provide new, visual information regarding immune surveillance and antigen presentation within the CNS. Furthermore, when combining intravital 2P-LSM and microfluidic devices complexed with mathematical modeling, we are gaining new insights into the intravascular behavior of circulating immune cells. This new knowledge into the basic mechanisms by which cells migrate to and interact with the CNS provide important considerations for the design of neuroelectric devices that have the potential to connect the peripheral-neural microenvironments in a unique, artificial interface.
- 17 July 2019
- Published by Frontiers Media SA in Frontiers in Neuroscience
- Vol. 13, 737
Open AccessInsights From Dynamic Neuro-Immune Imaging on Murine Immune Responses to CNS Damage
Technological advances in 2-Photon Laser Scanning Microscopy (2P-LSM) have allowed novel insights into in vivo immune response in a variety of tissue microenvironments. While imaging of peripheral tissues has provided an abundance of data with regards to immune cell dynamics, central nervous system (CNS) imaging is comparatively inhibited by tissue accessibility and manipulation. Despite these limitations, the results of dynamic intravital neuro-immune imaging thus far have provided foundational insights into basic CNS biology. Utilizing a combination of intravital and ex vivo 2P-LSM we have observed novel pathways allowing immune cells, stromal cells, cancer cells and proteins to communicate between the CNS parenchyma and peripheral vasculature. Similar to what has been reported in the intestinal tract, we have visualized myeloid cells extend dendritic processes across the blood brain barrier (BBB) into pial blood vessels. Furthermore, transient vessel leaks seen during systemic inflammation provide opportunities for cellular protein to be exchanged between the periphery and CNS. These insights provide new, visual information regarding immune surveillance and antigen presentation within the CNS. Furthermore, when combining intravital 2P-LSM and microfluidic devices complexed with mathematical modeling, we are gaining new insights into the intravascular behavior of circulating immune cells. This new knowledge into the basic mechanisms by which cells migrate to and interact with the CNS provide important considerations for the design of neuroelectric devices that have the potential to connect the peripheral-neural microenvironments in a unique, artificial interface.
- Top Cited PapersOpen Access
- 3 August 2018
- Published by American Association for the Advancement of Science (AAAS) in Science Immunology
- Vol. 3 (26)
Chemical disruption of the pyroptotic pore-forming protein gasdermin D inhibits inflammatory cell death and sepsis
Necrosulfonamide inhibits pyroptosis through direct inhibition of gasdermin D.
- 3 August 2018
- Published by American Association for the Advancement of Science (AAAS) in Science Immunology
- Vol. 3 (26)
Top Cited PapersOpen AccessChemical disruption of the pyroptotic pore-forming protein gasdermin D inhibits inflammatory cell death and sepsis
Necrosulfonamide inhibits pyroptosis through direct inhibition of gasdermin D.
- Open Access
- 5 June 2018
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 7 (11)
Aryl Hydrocarbon Receptor Nuclear Translocator in Vascular Smooth Muscle Cells Is Required for Optimal Peripheral Perfusion Recovery
Background: Limb ischemia resulting from peripheral vascular disease is a common cause of morbidity. Vessel occlusion limits blood flow, creating a hypoxic environment that damages distal tissue, requiring therapeutic revascularization. Hypoxia‐inducible factors ( HIF s) are key transcriptional regulators of hypoxic vascular responses, including angiogenesis and arteriogenesis. Despite vascular smooth muscle cells’ ( VSMC s’) importance in vessel integrity, little is known about their functional responses to hypoxia in peripheral vascular disease. This study investigated the role of VSMC HIF in mediating peripheral ischemic responses. Methods and Results: We used Arnt SMKO mice with smooth muscle–specific deletion of aryl hydrocarbon receptor nuclear translocator (ARNT, HIF ‐1β), required for HIF transcriptional activity, in a femoral artery ligation model of peripheral vascular disease. Arnt SMKO mice exhibit impaired perfusion recovery despite normal collateral vessel dilation and angiogenic capillary responses. Decreased blood flow manifests in extensive tissue damage and hypoxia in ligated limbs of Arnt SMKO mice. Furthermore, loss of aryl hydrocarbon receptor nuclear translocator changes the proliferation, migration, and transcriptional profile of cultured VSMC s. Arnt SMKO mice display disrupted VSMC morphologic features and wrapping around arterioles and increased vascular permeability linked to decreased local blood flow. Conclusions: Our data demonstrate that traditional vascular remodeling responses are insufficient to provide robust peripheral tissue reperfusion in Arnt SMKO mice. In all, this study highlights HIF responses to hypoxia in arteriole VSMC s critical for the phenotypic and functional stability of vessels that aid in the recovery of blood flow in ischemic peripheral tissues.
- 5 June 2018
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 7 (11)
Open AccessAryl Hydrocarbon Receptor Nuclear Translocator in Vascular Smooth Muscle Cells Is Required for Optimal Peripheral Perfusion Recovery
Background: Limb ischemia resulting from peripheral vascular disease is a common cause of morbidity. Vessel occlusion limits blood flow, creating a hypoxic environment that damages distal tissue, requiring therapeutic revascularization. Hypoxia‐inducible factors ( HIF s) are key transcriptional regulators of hypoxic vascular responses, including angiogenesis and arteriogenesis. Despite vascular smooth muscle cells’ ( VSMC s’) importance in vessel integrity, little is known about their functional responses to hypoxia in peripheral vascular disease. This study investigated the role of VSMC HIF in mediating peripheral ischemic responses. Methods and Results: We used Arnt SMKO mice with smooth muscle–specific deletion of aryl hydrocarbon receptor nuclear translocator (ARNT, HIF ‐1β), required for HIF transcriptional activity, in a femoral artery ligation model of peripheral vascular disease. Arnt SMKO mice exhibit impaired perfusion recovery despite normal collateral vessel dilation and angiogenic capillary responses. Decreased blood flow manifests in extensive tissue damage and hypoxia in ligated limbs of Arnt SMKO mice. Furthermore, loss of aryl hydrocarbon receptor nuclear translocator changes the proliferation, migration, and transcriptional profile of cultured VSMC s. Arnt SMKO mice display disrupted VSMC morphologic features and wrapping around arterioles and increased vascular permeability linked to decreased local blood flow. Conclusions: Our data demonstrate that traditional vascular remodeling responses are insufficient to provide robust peripheral tissue reperfusion in Arnt SMKO mice. In all, this study highlights HIF responses to hypoxia in arteriole VSMC s critical for the phenotypic and functional stability of vessels that aid in the recovery of blood flow in ischemic peripheral tissues.
- Open Access
- 1 September 2017
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 292 (35) , 14649-14658
Live-cell visualization of gasdermin D-driven pyroptotic cell death
- 1 September 2017
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 292 (35) , 14649-14658
Open AccessLive-cell visualization of gasdermin D-driven pyroptotic cell death
- Open Access
- 1 December 2015
- Published by Wolters Kluwer Health in Neurology Neuroimmunology & Neuroinflammation
- Vol. 2 (6) , e174
Spatiotemporal ablation of CXCR2 on oligodendrocyte lineage cells
Background: Residual CXCR2 expression on CNS cells in Cxcr2+/−→Cxcr2−/− chimeric animals slowed remyelination after both experimental autoimmune encephalomyelitis and cuprizone-induced demyelination. Methods: We generated Cxcr2fl/−:PLPCre-ER(T) mice enabling an inducible, conditional deletion of Cxcr2 on oligodendrocyte lineage cells of the CNS. Cxcr2fl/−:PLPCre-ER(T) mice were evaluated in 2 demyelination/remyelination models: cuprizone-feeding and in vitro lysophosphatidylcholine (LPC) treatment of cerebellar slice cultures. Results: Cxcr2fl/−:PLPCre-ER(T)+ (termed Cxcr2-cKO) mice showed better myelin repair 4 days after LPC-induced demyelination of cerebellar slice cultures. Cxcr2-cKOs also displayed enhanced hippocampal remyelination after a 2-week recovery from 6-week cuprizone feeding. Conclusion: Using 2 independent demyelination/remyelination models, our data document enhanced myelin repair in Cxcr2-cKO mice, consistent with the data obtained from radiation chimerism studies of germline CXCR2. Further experiments are appropriate to explore how CXCR2 function in the oligodendrocyte lineage accelerates myelin repair.
- 1 December 2015
- Published by Wolters Kluwer Health in Neurology Neuroimmunology & Neuroinflammation
- Vol. 2 (6) , e174
Open AccessSpatiotemporal ablation of CXCR2 on oligodendrocyte lineage cells
Background: Residual CXCR2 expression on CNS cells in Cxcr2+/−→Cxcr2−/− chimeric animals slowed remyelination after both experimental autoimmune encephalomyelitis and cuprizone-induced demyelination. Methods: We generated Cxcr2fl/−:PLPCre-ER(T) mice enabling an inducible, conditional deletion of Cxcr2 on oligodendrocyte lineage cells of the CNS. Cxcr2fl/−:PLPCre-ER(T) mice were evaluated in 2 demyelination/remyelination models: cuprizone-feeding and in vitro lysophosphatidylcholine (LPC) treatment of cerebellar slice cultures. Results: Cxcr2fl/−:PLPCre-ER(T)+ (termed Cxcr2-cKO) mice showed better myelin repair 4 days after LPC-induced demyelination of cerebellar slice cultures. Cxcr2-cKOs also displayed enhanced hippocampal remyelination after a 2-week recovery from 6-week cuprizone feeding. Conclusion: Using 2 independent demyelination/remyelination models, our data document enhanced myelin repair in Cxcr2-cKO mice, consistent with the data obtained from radiation chimerism studies of germline CXCR2. Further experiments are appropriate to explore how CXCR2 function in the oligodendrocyte lineage accelerates myelin repair.
- 1 December 2013
- Published by Oxford University Press (OUP)
Motor Skill Learning
Early neuroscience experiments of skill learning focused predominantly on motor cortical plasticity. More recently, experiments have shown that cognitive processes such as working memory and error detection are engaged in the service of motor skill learning, particularly early in the learning process. This engagement early in learning maps onto prefrontal and striatal brain regions. As learning progresses, skill performance becomes automated and is no longer associated with prefrontal cortical recruitment. “Choking under pressure” may involve a return to early learning cognitive control mechanisms, resulting in disruption of highly learned skills. Conversely, analogy learning may speed skill acquisition by allowing learners to bypass the more cognitively demanding early stages. Questions for the future include the relative involvement of and interaction between implicit and explicit memory systems for different types of skill learning, and the impact of experiential and genetic individual differences on learning success.
- 1 December 2013
- Published by Oxford University Press (OUP)
Motor Skill Learning
Early neuroscience experiments of skill learning focused predominantly on motor cortical plasticity. More recently, experiments have shown that cognitive processes such as working memory and error detection are engaged in the service of motor skill learning, particularly early in the learning process. This engagement early in learning maps onto prefrontal and striatal brain regions. As learning progresses, skill performance becomes automated and is no longer associated with prefrontal cortical recruitment. “Choking under pressure” may involve a return to early learning cognitive control mechanisms, resulting in disruption of highly learned skills. Conversely, analogy learning may speed skill acquisition by allowing learners to bypass the more cognitively demanding early stages. Questions for the future include the relative involvement of and interaction between implicit and explicit memory systems for different types of skill learning, and the impact of experiential and genetic individual differences on learning success.
- Open Access
- 19 March 2013
- Published by Oxford University Press (OUP) in Cerebral Cortex
- Vol. 24 (8) , 2151-2159
Dissociable Functional Networks of the Human Dentate Nucleus
The cerebellar dentate nucleus has been reported to project to motor and prefrontal cortical regions in nonhuman primates from 2 anatomically distinct areas. However, despite a wealth of human neuroimaging data implicating the cerebellum in motor and cognitive behaviors, evidence of dissociable motor and cognitive networks comprising the human dentate is lacking. To investigate the existence of these 2 networks in the human brain, we used resting-state functional connectivity magnetic resonance imaging. The resting-state fMRI signal was extracted from regions of interest in the dorsal and ventral dentate nucleus. We report a “motor” network involving the dorsal dentate, anterior regions of the cerebellum, and the precentral gyrus, and a “cognitive” network involving the ventral dentate, Crus I, and prefrontal cortex. The existence of these 2 distinct networks supports the notion that cerebellar involvement in cognitive tasks is above and beyond that associated with motor response components.
- 19 March 2013
- Published by Oxford University Press (OUP) in Cerebral Cortex
- Vol. 24 (8) , 2151-2159
Open AccessDissociable Functional Networks of the Human Dentate Nucleus
The cerebellar dentate nucleus has been reported to project to motor and prefrontal cortical regions in nonhuman primates from 2 anatomically distinct areas. However, despite a wealth of human neuroimaging data implicating the cerebellum in motor and cognitive behaviors, evidence of dissociable motor and cognitive networks comprising the human dentate is lacking. To investigate the existence of these 2 networks in the human brain, we used resting-state functional connectivity magnetic resonance imaging. The resting-state fMRI signal was extracted from regions of interest in the dorsal and ventral dentate nucleus. We report a “motor” network involving the dorsal dentate, anterior regions of the cerebellum, and the precentral gyrus, and a “cognitive” network involving the ventral dentate, Crus I, and prefrontal cortex. The existence of these 2 distinct networks supports the notion that cerebellar involvement in cognitive tasks is above and beyond that associated with motor response components.